To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC deal makes 16 times cost
3i and SEB Företagsinvest are selling Swedish vaccine distributor SBL Vaccines to Dutch biotechnology company Crucell for €39.4 million, generating an approximate 16 times return of the vendors’ investment.
